Revvity Price to Free Cash Flow Ratio 2010-2025 | RVTY
Historical price to free cash flow ratio values for Revvity (RVTY) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Revvity Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-14 | 91.02 | 21.20 | |
| 2025-03-31 | 105.72 | $4.29 | 24.63 |
| 2024-12-31 | 111.46 | $4.41 | 25.27 |
| 2024-09-30 | 127.51 | $4.57 | 27.88 |
| 2024-06-30 | 104.59 | $3.09 | 33.88 |
| 2024-03-31 | 104.66 | $0.79 | 131.95 |
| 2023-12-31 | 108.88 | $0.08 | 1371.32 |
| 2023-09-30 | 110.19 | $-0.46 | 0.00 |
| 2023-06-30 | 118.18 | $1.21 | 97.94 |
| 2023-03-31 | 132.51 | $3.01 | 43.99 |
| 2022-12-31 | 139.35 | $4.70 | 29.65 |
| 2022-09-30 | 119.52 | $6.35 | 18.81 |
| 2022-06-30 | 141.19 | $7.53 | 18.75 |
| 2022-03-31 | 173.13 | $9.30 | 18.62 |
| 2021-12-31 | 199.44 | $11.35 | 17.57 |
| 2021-09-30 | 171.83 | $13.11 | 13.10 |
| 2021-06-30 | 153.04 | $12.43 | 12.31 |
| 2021-03-31 | 127.08 | $11.16 | 11.39 |
| 2020-12-31 | 142.08 | $7.43 | 19.12 |
| 2020-09-30 | 124.20 | $4.89 | 25.40 |
| 2020-06-30 | 97.00 | $3.99 | 24.31 |
| 2020-03-31 | 74.38 | $3.16 | 23.57 |
| 2019-12-31 | 95.87 | $2.58 | 37.16 |
| 2019-09-30 | 84.02 | $1.99 | 42.21 |
| 2019-06-30 | 94.97 | $2.18 | 43.66 |
| 2019-03-31 | 94.92 | $2.41 | 39.45 |
| 2018-12-31 | 77.31 | $2.29 | 33.71 |
| 2018-09-30 | 95.66 | $2.17 | 44.04 |
| 2018-06-30 | 71.96 | $1.61 | 44.63 |
| 2018-03-31 | 74.33 | $1.49 | 49.83 |
| 2017-12-31 | 71.72 | $2.26 | 31.74 |
| 2017-09-30 | 67.58 | $2.71 | 24.91 |
| 2017-06-30 | 66.70 | $2.68 | 24.86 |
| 2017-03-31 | 56.76 | $3.29 | 17.27 |
| 2016-12-31 | 50.92 | $3.08 | 16.52 |
| 2016-09-30 | 54.71 | $2.63 | 20.83 |
| 2016-06-30 | 51.05 | $2.70 | 18.91 |
| 2016-03-31 | 48.10 | $2.22 | 21.66 |
| 2015-12-31 | 52.02 | $2.28 | 22.77 |
| 2015-09-30 | 44.56 | $2.10 | 21.24 |
| 2015-06-30 | 50.97 | $2.11 | 24.11 |
| 2015-03-31 | 49.45 | $2.01 | 24.61 |
| 2014-12-31 | 42.22 | $2.26 | 18.69 |
| 2014-09-30 | 42.02 | $1.99 | 21.07 |
| 2014-06-30 | 45.08 | $2.32 | 19.46 |
| 2014-03-31 | 43.29 | $2.06 | 20.98 |
| 2013-12-31 | 39.55 | $1.51 | 26.13 |
| 2013-09-30 | 36.14 | $1.14 | 31.74 |
| 2013-06-30 | 31.05 | $0.39 | 78.67 |
| 2013-03-31 | 32.07 | $0.86 | 37.40 |
| 2012-12-31 | 30.20 | $0.96 | 31.60 |
| 2012-09-30 | 27.98 | $1.44 | 19.44 |
| 2012-06-30 | 24.42 | $1.72 | 14.19 |
| 2012-03-31 | 26.11 | $1.50 | 17.44 |
| 2011-12-31 | 18.82 | $1.71 | 11.01 |
| 2011-09-30 | 18.01 | $1.19 | 15.08 |
| 2011-06-30 | 25.17 | $0.90 | 27.93 |
| 2011-03-31 | 24.50 | $1.15 | 21.33 |
| 2010-12-31 | 24.02 | $1.20 | 20.01 |
| 2010-09-30 | 21.46 | $1.49 | 14.36 |
| 2010-06-30 | 19.10 | $1.72 | 11.13 |
| 2010-03-31 | 22.02 | $1.33 | 16.59 |
| 2009-12-31 | 18.91 | $1.06 | 17.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.399B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.708B | 26.39 |
| Elevance Health (ELV) | United States | $84.816B | 10.94 |
| CVS Health (CVS) | United States | $76.534B | 9.51 |
| Cencora (COR) | United States | $54.103B | 18.81 |
| DiDi Global (DIDIY) | China | $21.367B | 32.43 |
| Natera (NTRA) | United States | $20.793B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.720B | 13.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.739B | 0.00 |
| CochLear (CHEOY) | Australia | $11.361B | 0.00 |
| ICON (ICLR) | Ireland | $11.346B | 10.55 |
| Doximity (DOCS) | United States | $11.282B | 58.67 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $9.063B | 13.17 |
| Medpace Holdings (MEDP) | United States | $8.914B | 23.68 |
| HealthEquity (HQY) | United States | $8.389B | 41.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.074B | 13.86 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| BrightSpring Health Services (BTSG) | United States | $4.049B | 37.48 |
| Sotera Health (SHC) | United States | $3.758B | 21.35 |
| Surgery Partners (SGRY) | United States | $2.939B | 38.22 |
| Alignment Healthcare (ALHC) | United States | $2.780B | 0.00 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.194B | 2.33 |
| Premier (PINC) | United States | $2.087B | 14.29 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| GeneDx Holdings (WGS) | United States | $1.739B | 66.96 |
| PACS (PACS) | United States | $1.669B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.650B | 30.71 |
| Teladoc Health (TDOC) | United States | $1.337B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.239B | 9.42 |
| Agilon Health (AGL) | United States | $1.118B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.011B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.898B | 14.03 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| Embecta (EMBC) | United States | $0.731B | 4.92 |
| Nutex Health (NUTX) | United States | $0.696B | 10.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Enhabit (EHAB) | United States | $0.530B | 43.62 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 13.51 |
| Sonida Senior Living (SNDA) | United States | $0.510B | 0.00 |
| LifeMD (LFMD) | United States | $0.387B | 0.00 |
| SBC Medicals (SBC) | United States | $0.363B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.362B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Sera Prognostics (SERA) | United States | $0.089B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| KindlyMD (KDLY) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |